News

Vilvoorde, September 21, 2021 - A study examining joint pain in physically active middle-aged people has found that consuming SOLUGEL® collagen peptides can bring about significant reductions in pain and discomfort. This unique research was carried out by Florida State University (FSU) and commissioned by PB Leiner.

Vilvoorde, April 22, 2021 - Collagen’s star is rising fast – but is it just a passing trend? Not according to industry experts, who say that the protein is set to become a major force in the health ingredients category.

Vilvoorde, September 8, 2020 – PB Leiner proudly presents SOLUGEL® Dynamica, its exciting new collagen solution for functional bars and beverages, two applications which are typically challenging to produce. The new product will allow customers to easily formulate delicious trendy products that boast all the health benefits of collagen.

​Vilvoorde, September 8, 2020 – PB Leiner introduces gelwoRx™, a new product family which it has created to effectively address the needs of the health care sector. The launch is being jumpstarted by the release of two soft capsule specialty products: gelwoRx™ Dsolve enhances the bioavailability of the capsule API by counteracting the natural...

Vilvoorde, August 27, 2020 - PB Leiner and Zhejiang Shengda Ocean Co., Ltd. from Zhoushan (P.R. China) have established a joint venture to construct a bone and marine collagen peptides plant. Under the terms of this agreement, PB Shengda (Zhejiang) Biotechnology Co., Ltd. will produce bone and marine collagen peptides based on PB Leiner’s...

Vilvoorde, February 12, 2020 - PB Leiner (part of Tessenderlo Group) has inaugurated a new collagen peptides line today at its site in Santa Fe (Argentina). The added production facility will allow for a considerable extra production volume of SOLUGEL™ collagen peptides. “Global demand for collagen peptides is on the rise, on account of its...